Latest Biotech News

Researchers have demonstrated unprecedented capabilities of artificial intelligence in protein and genome editing design, surpassing natural biological processes. Collaborations between Integra...

Scientists at the University of British Columbia have achieved the first successful human trial converting a kidney from blood type A to the universal type O using specialized enzymes. Published...

Recent clinical and preclinical studies highlight key therapeutic advances across oncology and neurology. Amgen’s cholesterol-lowering drug Repatha demonstrated cardiovascular event reduction in a...

Artificial intelligence continues to transform drug discovery and genomics through innovative platforms and partnerships. Nanyang Biologics merged with Nasdaq-listed RF Acquisition Corp II to...

Recent studies delve into cancer biology, revealing mechanisms of tumor progression and immune interactions. Genialis and Cleveland Clinic collaborate on AI-assisted biomarkers for pancreatic...

Breakthrough discoveries are advancing understanding and treatment options for neurodegenerative and autoimmune diseases. Studies reveal an autoimmune component in amyotrophic lateral sclerosis,...

Major biotech companies and investors are repositioning amidst shifting priorities. Takeda announces exit from all cell therapy research, ceasing clinical trials and seeking external partners,...

Cutting-edge diagnostic tools and screening programs continue to evolve, enhancing disease detection and monitoring. Rockefeller Center hosted a large-scale hereditary cancer genetic testing...

Innovative techniques are transforming molecular biology and disease research. The University of California San Diego developed a technology mapping complex RNA-protein interaction networks inside...

Artificial intelligence is increasingly central to ensuring drug safety and optimizing biomanufacturing processes. Microsoft’s studies highlight AI’s dual-use potential in protein engineering,...

Researchers at the University of British Columbia have pioneered a first-in-human trial converting blood type A kidneys to universal type O using specialized enzymes. This landmark achievement,...

Japanese pharmaceutical giant Takeda Pharmaceutical Co. Ltd. announced a complete withdrawal from all cell therapy research and development activities. The company will seek external partners to...

Amgen reported compelling new data from a clinical trial demonstrating its cholesterol-lowering injection Repatha’s ability to reduce the risk of a composite endpoint including heart disease...

Cartography Biosciences, a biotech developing T-cell engaging bispecific and multispecific antibody therapeutics for cancer, closed a $67 million Series B financing led by Pfizer Ventures. The...

Pharmaceutical companies including Abbvie, Johnson & Johnson, Bristol Myers Squibb, Takeda, and Astex have collaborated through the AI Structural Biology network to share proprietary...

Researchers at the La Jolla Institute for Immunology and Columbia University Irving Medical Center have uncovered compelling evidence suggesting that amyotrophic lateral sclerosis (ALS) may be...

Matthew Padula and collaborators have utilized Deep Visual Proteomics (DVP), combining imaging, laser isolation, and high-resolution mass spectrometry, to generate a spatial map of a rare bladder...

Several biotech companies face regulatory challenges as the FDA and authorities grapple with resource limitations amid a government funding lapse. Fortress Biotech received a Complete Response...

Memorial Sloan Kettering Cancer Center presented multiple groundbreaking radiation therapy studies at the 2025 ASTRO meeting, highlighting novel approaches to improve treatment efficacy across...

Danish biotech Genmab completed an $8 billion all-cash purchase of clinical-stage Merus, marking its largest acquisition and a strategic pivot toward an integrated biotech model. The deal centers...